Literature DB >> 35712387

Ameloblastoma: Retrospective Study and Analysis of 102 Cases Over 10 Years, Single Centre, Institutional Experience.

Ramakant Dandriyal1, Vishakha Lal1, Kolli Yada Giri2, Niranjanaprasad Indra Bavanthabettu1, Archana Chaurasia1, Swati Pant1.   

Abstract

Objective: The purpose of the study was to analyse the long-term results of ameloblastoma, which was treated at our centre. Study Design: We carried out a retrospective study of 10 years of clinical records from 2007 to 2016 with 102 consecutive cases of ameloblastoma. Data of all patients were collected and analysed with follow-up to 9 years.
Results: The data analysis revealed male (59.8%) predominance over female (40.2%) with a mean age of 30.35 ± 15.12 years was observed. We have observed a mandibular (93.1%) than maxilla (6.9%) with left side predominance (54.9%). Anatomically, in the mandible, most of the cases were located in ramus (27.5%). On radiographic analysis, multilocular lesion (66.4%) was observed in association with involvement of impacted mandibular third molar teeth. On histopathological examination, conventional type (63.8%) was most commonly noted. The most frequently performed procedure was segmental mandibulectomy (30.4%). Reconstruction was done in most of the cases by recon plate (41.2%). The recurrence rate was seen at about 20.6%.
Conclusion: Ameloblastoma has got mandibular posterior region with male predominance. Follicular ameloblastoma was the most common histological type found. So, Radical approach for adult patients wherein younger and growing patients conservative approach could be a justified as a treatment of choice. © The Association of Oral and Maxillofacial Surgeons of India 2022.

Entities:  

Keywords:  Ameloblastoma; Hemangeomatous ameloblastoma; Impacted third molar teeth; Mandibulectomy; Multilocular lesion; Reconstruction; Recurrence rate

Year:  2022        PMID: 35712387      PMCID: PMC9192859          DOI: 10.1007/s12663-022-01694-6

Source DB:  PubMed          Journal:  J Maxillofac Oral Surg        ISSN: 0972-8270


  42 in total

1.  Ameloblastoma--management and review of literature.

Authors:  J A Mallick; S A Ali
Journal:  J Pak Med Assoc       Date:  2002-10       Impact factor: 0.781

2.  Risk factors for recurrence of ameloblastoma: a long-term follow-up retrospective study.

Authors:  S W Au; K Y Li; W S Choi; Y X Su
Journal:  Int J Oral Maxillofac Surg       Date:  2019-05-11       Impact factor: 2.789

3.  Hemangiomatous Ameloblastoma- A Case Report of a Very Rare Variant of Ameloblastoma.

Authors:  Maruthi Devi Kasangari; Kiran Gundamaraju; Mandapati Jyothsna; Andy Venkata Subash; Kumbakonam Aravind
Journal:  J Clin Diagn Res       Date:  2015-05-01

4.  Clinicopathologic features of ameloblastoma in Kenya: a 10-year audit.

Authors:  Vilembwa L Adeline; Elizabeth A O Dimba; Kevin A Wakoli; Anthony K Njiru; David O Awange; John F Onyango; Mark L Chindia
Journal:  J Craniofac Surg       Date:  2008-11       Impact factor: 1.046

5.  Retrospective study of ameloblastoma: the possibility of conservative treatment.

Authors:  Takumi Hasegawa; Yusuke Imai; Daisuke Takeda; Daisuke Yasuoka; Shinshou Ri; Takashi Shigeta; Tsutomu Minamikawa; Yasuyuki Shibuya; Takahide Komori
Journal:  Kobe J Med Sci       Date:  2013-11-09

6.  Surgical management of ameloblastoma: Conservative or radical approach.

Authors:  Ramakant Dandriyal; Atul Gupta; Swati Pant; Hitesh Hans Baweja
Journal:  Natl J Maxillofac Surg       Date:  2011-01

Review 7.  Odontogenic tumors: where are we in 2017 ?

Authors:  John M Wright; Merva Soluk Tekkesin
Journal:  J Istanb Univ Fac Dent       Date:  2017-12-02

8.  Analysis of prevalence and clinical features of multicystic ameloblastoma and its histological subtypes in South Indian sample population: A retrospective study over 13 years.

Authors:  Manickam Selvamani; Andamuthu Yamunadevi; Praveen S Basandi; G S Madhushankari
Journal:  J Pharm Bioallied Sci       Date:  2014-07

9.  Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review.

Authors:  Rogelio González-González; Sandra López-Verdín; Jesús Lavalle-Carrasco; Nelly Molina-Frechero; Mario Isiordia-Espinoza; Ramón G Carreón-Burciaga; Ronell Bologna-Molina
Journal:  World J Clin Oncol       Date:  2020-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.